USPTO serial 79074204
NPC
Reviewed by CopyMark Law Group
Reg. 3899327Status 404
- Filing date
- Status date
- Registration date
- Jan 4, 2011
- Examiner
- CARL III, FRED
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with NPC?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medicines and chemico-pharmaceutical preparations for human use, namely, pharmaceutical preparations used to diminish inflammation, ease pain, relieve itch, allay a fever, stop bleeding, reduce swelling, eliminate mucus; pharmaceutical preparations for the treatment of influenza, muscle spasms, pain, dementia, loss of brain function, poor blood flow; pharmaceutical preparations for the treatment of rheumatism and arthritis; pharmaceutical preparations for the treatment of blood-lipid and blood pressure, convulsions, epilepsy, dementia, depression, mania, anxiety, hallucinations, ataxia, schizophrenia, mental diseases, psychonosema, tremors, hypersensitivity, restlessness, scurvy, diabetes, obesity, neuropathy, psychoneurosis, neuronal diseases, parasitosis, heart attack, dermatosis, ophthalmopathy, otopathy, rhinopathy, laryngopathy, neurological diseases, lung diseases, intestinal diseases, stomach diseases, liver diseases, biliary tract diseases, kidney disease, cancer, stomatopathy, gynecological diseases, obstetrical diseases, angionosis, skeletal diseases, muscular diseases, hematopathy, endocrinopathic diseases, urogenital diseases, genital diseases, respiratory failure; pharmaceuticals, namely, immuno-modulators; pharmaceuticals, namely, central nerve stimulants; hypnotics, sedatives, antithrombotics; pharmaceutical preparations for the treatment of lack of inorganic salts, sprain, wounds, apoplexy, heatstroke; antidotes; anti-senility drugs; anaesthetics; narcotics; styptic pencils; pesticides for agricultural, commercial, industrial, domestic use; teeth filling amalgams; dietetic foods adapted for medical use; sanitary napkins; sanitary sterilizing preparations; depuratives for the body; biochemical preparations for medical or veterinary purposes, namely, immune globulins; chemical reagents for medical or veterinary purposes, namely, pharmaceuticals for the treatment of heart conditions in horses; diagnostic preparations for medical or veterinary purposes, namely, medical and veterinary medical diagnostic reagents; greases and petroleum jelly for medical or veterinary purposes; plant extracts for medical, veterinary and pharmaceutical purposes; yeast or yeast extracts for medical, veterinary or pharmaceutical purposes | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by NHWA PHARMACEUTICAL CORPORATION
- Other trademarks owned by NHWA PHARMACEUTICAL CORPORATION
- Other trademarks owned by NHWA PHARMACEUTICAL CORPORATION
- Other trademarks in Class 005
- Similar marks named NPC
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 8, 2019 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| Nov 8, 2019 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| May 11, 2018 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Apr 17, 2018 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Apr 17, 2018 | INPC | INVALIDATION PROCESSED | — |
| Apr 11, 2018 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Aug 11, 2017 | C71T | CANCELLED SECTION 71 | — |
| Feb 18, 2013 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 2, 2011 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 2, 2011 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 4, 2011 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 4, 2011 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 19, 2010 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 19, 2010 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 14, 2010 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Sep 13, 2010 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 9, 2010 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 9, 2010 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 9, 2010 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 9, 2010 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Mar 26, 2010 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 26, 2010 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 11, 2010 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 11, 2010 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 10, 2010 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 12, 2010 | NAUD | NOTICE OF UNRESPONSIVE AMENDMENT - MAILED | — |
| Feb 9, 2010 | NAUD | REPORT UNRESPONSIVE AMENDMENT - COMPLETED | — |
| Jan 6, 2010 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 6, 2010 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 6, 2010 | ALIE | ASSIGNED TO LIE | — |
| Dec 24, 2009 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 18, 2009 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 24, 2009 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 24, 2009 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 24, 2009 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 23, 2009 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 21, 2009 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 17, 2009 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 17, 2009 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 12, 2009 | LIMS | LIMITATION OF GOODS/SERVICES FROM IB ENTERED | — |
| Nov 12, 2009 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |